Damora Therapeutics (DMRA) Capital Expenditures (QoQ) (2021 - 2025)
Damora Therapeutics (DMRA) Capital Expenditures (QoQ) (2021 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Damora Therapeutics | 1.00 Bn | 798.11 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -383.73% |
| Sep 30, 2025 | 31.11% |
| Jun 30, 2025 | 49.01% |
| Mar 31, 2025 | 107.77% |
| Dec 31, 2024 | -1,761.54% |
| Sep 30, 2024 | -57.45% |
| Jun 30, 2024 | -52.75% |
| Mar 31, 2024 | 145.15% |
| Dec 31, 2023 | -1,979.03% |
| Sep 30, 2023 | -588.89% |
| Jun 30, 2023 | -104.25% |
| Mar 31, 2023 | 107.84% |
| Dec 31, 2022 | -26.09% |
| Sep 30, 2022 | 630.77% |
| Jun 30, 2022 | -160.47% |
| Mar 31, 2022 | 115.00% |
| Dec 31, 2021 | 103.13% |
| Sep 30, 2021 | -182.22% |
| Jun 30, 2021 | 1,093.85% |